Ireland· IE-PA-PA2059/024/001
Addiphos concentrate for solution for infusion
A elektrolyte, kombinationen product containing potassium dihydrogen phosphate + potassium hydroxide + disodium phosphate dihydrate, registered in Ireland by Fresenius Kabi Deutschland GmbH. The same ATC class is registered in 5 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Elektrolyte, kombinationen is registered in 5 of 19 countries.
Countries holding a registration under ATC B05XA30 (elektrolyte, kombinationen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 2 of them publish a price we can compare per daily dose
Elektrolyte, kombinationen · ATC B05XA30
5 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
The record
At a glance
HPRA (Ireland)- Active substance
- Potassium dihydrogen phosphate + Potassium hydroxide + Disodium phosphate dihydrate
- Manufacturer
- Fresenius Kabi Deutschland GmbH
- Country
- Ireland (IE)
- ATC code
- B05XA30
- ATC class
- Elektrolyte, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2059/024/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Elektrolyte, kombinationen in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Poland · Addiphos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2e62ab0-c611-429d-8905-d00141264ac6 GET /v1/drugs/b2e62ab0-c611-429d-8905-d00141264ac6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B05XA",
"B05XA30"
],
"strength": null,
"pa_number": "PA2059/024/001",
"substances": [
"Potassium dihydrogen phosphate",
"Potassium hydroxide",
"Disodium phosphate dihydrate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "01/04/1983",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about elektrolyte, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.